Company / R&D Expense
NU SKIN ENTERPRISES, INC. R&D Expense History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest R&D Expense
$10.8M
FY2025
5-year range
$10.8M / $30.1M
FY2021-FY2025
Trend
-16.9%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
R&D Expense has declined for 4 consecutive years, from $30M in FY2021 to $11M in FY2025.
Based on SEC 10-K filings.
$11M in FY2025 with a 5-year CAGR of -14.0%.
Declined from $23M to $11M over the past 2 years.
R&D Expense over time
Growth rates
- 3-Year CAGR
- -22.6%
- 5-Year CAGR
- -14.0%
- 10-Year CAGR
- -
Key checks
Key Insights
- NU SKIN ENTERPRISES, INC.'s r&d expense has declined for 4 consecutive years.
- 5-year CAGR of -14.0%, indicating a declining trend.
- In FY2025, r&d expense decreased 16.9% year-over-year.
- Peak r&d expense was recorded in FY2021.
Company context
Key Data Points
- Altman Z-Score 3.03 (safe zone, above 2.9 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | R&D ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $10.8M | -16.9% |
| FY2024 | $13.0M | -42.5% |
| FY2023 | $22.6M | -3.0% |
| FY2022 | $23.3M | -22.6% |
| FY2021 | $30.1M | +30.9% |
| FY2020 | $23.0M | +4.5% |
| FY2019 | $22.0M | -9.5% |
| FY2018 | $24.3M | +20.9% |
| FY2017 | $20.1M | +6.3% |
| FY2016 | $18.9M | +5.0% |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026